company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3184000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3184000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,79000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,399000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,887000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9623000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5074000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5074000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-60151000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,22000000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-38151000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-38151000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,42000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,42000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,42000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-43183000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2199000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2199000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,78000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,601000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1557000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6417000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5096000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5096000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-78410000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,22250000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-56160000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-56160000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1347000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1347000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1347000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-59909000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:06:20+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,136000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:06:20+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,136000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:06:20+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,77000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:06:20+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,684000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:06:20+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1604000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:06:20+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5765000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:06:20+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3264000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:06:20+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3264000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:06:20+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,0.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:06:20+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-47400000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:06:20+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,60625000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:06:20+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,13225000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:06:20+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,13225000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:06:20+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,9961000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3074000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3074000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,146000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1725000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1254000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7253000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7202000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7170000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-34000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-51061000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,68700000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-500000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,17105000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,17105000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,9940000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5523000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5523000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,185000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,503000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1318000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8840000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12357000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12357000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-77000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-19576000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,59587000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,39934000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,39934000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,20000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,20000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,20000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,27597000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 06:57:02+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7962000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 06:57:02+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7962000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 06:57:02+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,331000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 06:57:02+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,486000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 06:57:02+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3130000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 06:57:02+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4675000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 06:57:02+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8690000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 06:57:02+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8690000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 06:57:02+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1845000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 06:57:02+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-29194000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 06:57:02+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,59900000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 06:57:02+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,28861000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 06:57:02+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,28861000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q1,2012-01-01,2012-03-31,2013-05-10 06:57:02+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,20171000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8007000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8007000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,93000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,537000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1290000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6127000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12214000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12214000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-148000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-20773000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,19429000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1492000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1492000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13706000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5326000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5326000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,104000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,511000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,577000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6030000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10164000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10164000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-17000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,20308000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,20291000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,20291000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,10127000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7322000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7322000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,105000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,521000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1876000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9029000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13849000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13849000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-10899000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9000000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1906000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1906000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,12000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,12000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,12000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-15743000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 07:01:57+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4519000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 07:01:57+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4519000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 07:01:57+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,107000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 07:01:57+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,489000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 07:01:57+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1298000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 07:01:57+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6500000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 07:01:57+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9125000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 07:01:57+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9125000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 07:01:57+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 07:01:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 07:01:57+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,23000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 07:01:57+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,30500000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 07:01:57+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 07:01:57+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,30523000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 07:01:57+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,30477000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 07:01:57+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-193000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 07:01:57+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-193000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 07:01:57+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-193000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 07:01:57+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,21159000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3383000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3383000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,105000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,373000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1134000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6272000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8043000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8043000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,46000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,905000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,951000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,794000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,794000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,794000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6298000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5406000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5406000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,109000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,377000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1565000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6916000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10271000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10271000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,48552000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,265000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,48817000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,48817000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,38539000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7747000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7747000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,111000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,411000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-25278000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,20350000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12153000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12153000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-97000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-65598000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,-1000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-65696000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-65696000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-47000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,488000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,441000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,441000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-77408000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:32:24+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26533000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:32:24+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26533000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:32:24+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,125000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:32:24+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,618000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:32:24+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1393000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:32:24+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,493000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:32:24+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-23904000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:32:24+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-23904000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:32:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-135000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:32:24+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-8000000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:32:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2319000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:32:24+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10698000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:32:24+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,145000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:32:24+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,389000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:32:24+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,389000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:32:24+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2011000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:32:24+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2011000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:32:24+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2011000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:32:24+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-21504000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21575000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21575000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,139000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,660000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1443000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-17332000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-36665000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-36665000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-243000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,8000000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-18225000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,28735000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-7900000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,10367000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,10367000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,32000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,32000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,32000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-26266000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1425000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1425000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,132000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,572000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1411000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8289000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7599000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7599000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-53000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-8000000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-19839000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,25607000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,8000000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5715000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5715000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,198000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,198000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,198000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1686000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,69719000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,69719000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,134000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,578000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-75251000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8566000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13386000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13386000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-338000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-52960000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,24790000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-28508000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-28508000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,87313000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,174000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,87487000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,87487000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,45593000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:02:10+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10221000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:02:10+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10221000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:02:10+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,140000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:02:10+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,4341000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:02:10+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,16372000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:02:10+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5077000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:02:10+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5555000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:02:10+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5555000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:02:10+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-783000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:02:10+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-59890000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:02:10+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,27105000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:02:10+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-33568000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:02:10+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-33568000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:02:10+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-79000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:02:10+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-79000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:02:10+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-79000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 07:02:10+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-28092000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5386000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5386000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,123000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3171000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,16198000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2005000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,12101000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,12101000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-156000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-21458000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,24449000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2835000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2835000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,592000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,592000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,592000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,15528000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9460000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9460000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,157000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3129000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5078000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3755000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4851000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4851000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-874000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-46261000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,46856000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-279000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-279000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3579000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3579000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3579000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1551000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14798000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14798000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,162000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3008000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5851000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5421000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-356000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-356000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-714000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-65502000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,70630000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4414000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4414000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4057000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 07:03:01+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12358000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 07:03:01+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12358000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 07:03:01+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,219000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 07:03:01+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2971000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 07:03:01+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-896000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 07:03:01+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5165000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 07:03:01+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4899000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 07:03:01+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4899000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 07:03:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-47311000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 07:03:01+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,40083000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 07:03:01+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7228000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 07:03:01+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7228000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 07:03:01+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,24000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 07:03:01+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,24000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 07:03:01+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,24000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q1,2016-01-01,2016-03-31,2017-05-03 07:03:01+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12103000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4618000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4618000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,216000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2957000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3740000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5557000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3262000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3262000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-111000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-56682000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,43494000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-13299000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-13299000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1015000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1015000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1015000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-15546000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-430000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-430000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,219000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2976000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1638000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3162000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1241000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1241000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-599000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-26865000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,29832000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2368000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2368000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5962000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5962000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5962000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,9571000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1183000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1183000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-697000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-34547000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,43378000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8134000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8134000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,750000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,750000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,750000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7701000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 17:03:04+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7645000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 17:03:04+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7645000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 17:03:04+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,250000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 17:03:04+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,401000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 17:03:04+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1792000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 17:03:04+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3429000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 17:03:04+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5357000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 17:03:04+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5357000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 17:03:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-478000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 17:03:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-53467000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 17:03:04+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,36777000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 17:03:04+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-17168000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 17:03:04+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-17168000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 17:03:04+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2209000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 17:03:04+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2209000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 17:03:04+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2209000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 17:03:04+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-20316000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1534000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1534000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,303000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,338000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4100000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5467000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2260000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2260000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-624000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-27704000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,22500000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5828000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5828000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2193000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2193000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2193000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5895000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4550000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4550000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,342000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,305000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2735000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,8806000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2168000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2168000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-371000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-28225000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,34000000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5404000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5404000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,768000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,768000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,768000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,8340000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1838000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1838000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,339000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,280000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,383000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4302000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3466000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3466000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-191000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-38739000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,46291000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7361000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7361000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,81000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,81000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,81000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,10908000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 07:02:25+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3066000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 07:02:25+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3066000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 07:02:25+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,349000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 07:02:25+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,144000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 07:02:25+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7723000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 07:02:25+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9644000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 07:02:25+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1638000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 07:02:25+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1638000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 07:02:25+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-135000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 07:02:25+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-30433000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 07:02:25+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,46880000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 07:02:25+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,16312000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 07:02:25+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,16312000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 07:02:25+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,101068000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 07:02:25+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2666000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 07:02:25+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,103734000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 07:02:25+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,103734000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q1,2018-01-01,2018-03-31,2019-05-03 07:02:25+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,121684000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4611000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4611000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,357000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-66000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2521000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3032000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4391000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4391000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-75000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-25000000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-100103000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,23915000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-101263000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-101263000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2488000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2488000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-94384000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,7171000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7171000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,351000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-317000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3402000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1913000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,8694000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,8694000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-136000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-71404000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,62635000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-8905000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-8905000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,112000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,112000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-99000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,10360000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10360000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,372000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-455000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6410000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1424000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,15263000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,15263000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-22000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-80455000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,64673000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-15804000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-15804000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,792000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,792000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,792000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,251000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 07:01:11+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-612000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 07:01:11+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-612000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 07:01:11+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,332000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 07:01:11+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-506000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 07:01:11+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4305000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 07:01:11+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6144000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 07:01:11+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,9663000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 07:01:11+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,9643000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 07:01:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-393000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 07:01:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-100803000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 07:01:11+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,64745000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 07:01:11+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-36451000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 07:01:11+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-36451000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 07:01:11+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,179000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 07:01:11+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,179000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 07:01:11+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,179000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 07:01:11+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-26629000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,11526000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11526000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,340000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-542000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4856000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4356000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,20495000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,20515000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-264000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-90490000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,79000000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11754000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11754000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3421000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3411000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3411000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,12172000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5998000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5998000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-294000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-100040000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,86460000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-13874000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-13874000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,558000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,558000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7318000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4216000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4216000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,365000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-102000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2813000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2499000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,9791000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,9791000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-68000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-103184000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,97022000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6230000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6230000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2116000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2116000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2116000.0
Vanda Pharmaceuticals Inc,VNDA,,0001347178,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5677000.0
